CRSP
CRISPR Therapeutics AG
$40.19+0.04 (+0.10%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Oct 19, 2016 – Nov 18, 2026, Dividends reinvested
- Final balance
- $28,524
- CAGR
- +10.96%
- Max drawdown
- −85.11%
Trailing returns (%)
CRSP's average annual return was 6.96% over the last 10 years, through Nov 18, 2026. $10,000 in CRSP on Nov 18, 2016 grew to $19,605 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −18.40%
- 3M
- −24.13%
- 6M
- −17.24%
- YTD
- −23.36%
- 1Y
- −24.84%
Per year
- 3Y
- −16.03%
- 5Y
- −13.50%
- 10Y
- +6.96%
- Since 2016
- +10.96%
Annual returns
2016 from Oct 19 · 2026 through Nov 18
CRSP returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | −23.36% |
| 2025 | +33.23% |
| 2024 | −37.12% |
| 2023 | +54.00% |
| 2022 | −46.36% |
| 2021 | −50.51% |
| 2020 | +151.39% |
| 2019 | +113.18% |
| 2018 | +21.68% |
| 2017 | +15.89% |
| 2016 from Oct 19 | +43.79% |
Metrics
Since 2016| Volatility | 63.94% |
|---|---|
| Sharpe ratio | 0.48 |
| Sortino ratio | 0.74 |
| Calmar ratio | 0.13 |
| Longest drawdown | 5.8 years |
Worst drawdowns
Since 2016| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −85.1% | Jan 2021 | Apr 2025 | Not yet | 5.8 years so far |
| −69.1% | May 2018 | Dec 2018 | Jun 2020 | 2.1 years |
| −42.6% | Feb 2017 | May 2017 | Jan 2018 | 10 months |
| −37.2% | Jan 2017 | Feb 2017 | Feb 2017 | 2 months |
| −26.7% | Mar 2018 | Apr 2018 | May 2018 | 2 months |